Payer Financial Performance

Rock Health provided a list of the biggest capital raises of 2025.

Experts suggest specialty drugs and upcoding could be fueling the issue.

Don’t call it a comeback.

From pharma to payers to hospitals, execs have had varying responses to current tariffs and those to come.

We thought Q1 was bad, but this is another level.

Who needs a five-star rating when you’ve got $32b in revenue and beef with the feds?

Medical bills aren’t just paying for treatment—they’re fueling record-breaking payouts.